Details for Patent: 10,028,912
✉ Email this page to a colleague
Which drugs does patent 10,028,912 protect, and when does it expire?
Patent 10,028,912 protects VYXEOS and is included in one NDA.
Protection for VYXEOS has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-four patent family members in twenty-two countries.
Summary for Patent: 10,028,912
| Title: | Method of lyophilizing liposomes |
| Abstract: | Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution. |
| Inventor(s): | Donna Cabral-Lilly, Lawrence Mayer, Paul Tardi, David Watkins, Yi Zeng |
| Assignee: | Jazz Pharmaceuticals Therapeutics Inc |
| Application Number: | US14/352,662 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 10,028,912
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms Therap | VYXEOS | cytarabine; daunorubicin | POWDER;INTRAVENOUS | 209401-001 | Aug 3, 2017 | RX | Yes | Yes | 10,028,912*PED | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,028,912
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2768484 | ⤷ Start Trial | 301016 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2768484 | ⤷ Start Trial | LUC00135 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 2768484 | ⤷ Start Trial | CA 2019 00051 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
